Krensavage Asset Management as of June 30, 2017
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 15 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bioverativ | 12.9 | $43M | 709k | 60.17 | |
| Enanta Pharmaceuticals (ENTA) | 12.1 | $40M | 1.1M | 35.98 | |
| Gilead Sciences (GILD) | 11.4 | $38M | 532k | 70.78 | |
| United Therapeutics Corporation (UTHR) | 10.8 | $35M | 273k | 129.73 | |
| Sucampo Pharmaceuticals | 9.0 | $30M | 2.8M | 10.50 | |
| Orthofix International Nv Com Stk | 8.2 | $27M | 584k | 46.48 | |
| RTI Biologics | 7.9 | $26M | 4.5M | 5.85 | |
| Merck & Co (MRK) | 7.4 | $25M | 382k | 64.09 | |
| Halyard Health | 6.8 | $22M | 571k | 39.28 | |
| Invacare Corporation | 4.5 | $15M | 1.1M | 13.20 | |
| Unilife US | 4.0 | $13M | 77k | 172.23 | |
| CONMED Corporation (CNMD) | 3.5 | $12M | 227k | 50.94 | |
| Aviragen Therapeutics | 0.6 | $1.9M | 2.8M | 0.67 | |
| Digirad Corporation | 0.4 | $1.4M | 334k | 4.05 | |
| Juniper Pharmaceuticals Incorporated | 0.4 | $1.2M | 243k | 5.05 |
